Reported Reactions

Devices › Device types

FDA product code NEK · class 3 · Unknown

Filler, recombinant human bone morphogenetic protein, collagen scaffold with metal prosthesis, osteoinduction: medical device reports filed with FDA

13,040 reports carry this product code, 2003–2026; 3 brands with a page.

13,040
reports with this product code
0.1% of all MAUDE reports
43
reports, 12 months to August 2026
53 in the 12 months before
0.7%
classified as malfunction
62.3% across all reports
0.3%
classified as death, as reported
0.9% across all reports

Product code NEK is FDA's classification for "Filler, recombinant human bone morphogenetic protein, collagen scaffold with metal prosthesis, osteoinduction" (unknown panel), a class 3 device. 13,040 medical device reports carry this product code, 0.1% of the MAUDE database, from March 2003 to July 2026.

43 reports arrived in the 12 months to August 2026, down 19% from 53 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (98.5%), malfunction (0.7%) and death (0.3%). 3 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
Infuse Bone Graft11,989360.3%0.4%
Medtronic Infuse Bone Graft Or Rhbmp247700%0%
Verte-Stack Spinal System500.5%63.2%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Medtronic Sofamor Danek USA12,00192%
Medtronic5554.3%
Medtronic Sofamor Danek2612%
Warsaw Orthopedics50%
Warsaw Orthopedic30%

Reports by month, five years

0611Sep 2021: 2Oct 2021: 0Nov 2021: 2Dec 2021: 22022Jan 2022: 2Feb 2022: 1Mar 2022: 0Apr 2022: 0May 2022: 0Jun 2022: 1Jul 2022: 2Aug 2022: 1Sep 2022: 0Oct 2022: 1Nov 2022: 0Dec 2022: 02023Jan 2023: 0Feb 2023: 2Mar 2023: 0Apr 2023: 0May 2023: 2Jun 2023: 1Jul 2023: 0Aug 2023: 3Sep 2023: 0Oct 2023: 1Nov 2023: 4Dec 2023: 12024Jan 2024: 0Feb 2024: 2Mar 2024: 6Apr 2024: 8May 2024: 0Jun 2024: 4Jul 2024: 3Aug 2024: 0Sep 2024: 1Oct 2024: 2Nov 2024: 9Dec 2024: 12025Jan 2025: 1Feb 2025: 2Mar 2025: 5Apr 2025: 4May 2025: 11Jun 2025: 6Jul 2025: 4Aug 2025: 7Sep 2025: 6Oct 2025: 3Nov 2025: 2Dec 2025: 12026Jan 2026: 2Feb 2026: 2Mar 2026: 7Apr 2026: 6May 2026: 4Jun 2026: 6Jul 2026: 4Aug 2026: 0

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death0.3%45
Injury98.5%12,845
Malfunction0.7%90
Other0.1%16
Not given0.3%44

Who filed

Manufacturer report94.8%12,361
Voluntary report5%656
User facility report0%0
Distributor report0%0
Not given0.2%23

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Insufficient device problem information1,0047.7%
Device remains implanted1180.9%
Device operates differently than expectedthe device behaved unexpectedly910.7%
Off-label use810.6%
Explanted580.4%
Migration or expulsion of device490.4%
Patient-device incompatibilitythe device did not suit the patient380.3%
Breakthe device broke230.2%
Osseointegration problem230.2%
Replace210.2%
Improper or incorrect procedure or method190.1%
Other (for use when an appropriate device code cannot be identified)110.1%
Failure to osseointegrate90.1%
Malposition of device90.1%
Device slipped80.1%
Nonstandard device80.1%
Loss of osseointegration60%
Collapse50%
Device dislodged or dislocated40%
Implant, removal of40%

Questions about filler, recombinant human bone morphogenetic protein, collagen scaffold with metal prosthesis, osteoinduction reports

What is product code NEK?

FDA's classification code for "Filler, recombinant human bone morphogenetic protein, collagen scaffold with metal prosthesis, osteoinduction", class 3, reviewed by the unknown panel. Every device report carries the product code of the device involved.

How many reports carry this code?

13,040 reports through August 2026, 43 of them in the latest 12 months.

Which brands appear most often?

Infuse Bone Graft (11,989), Medtronic Infuse Bone Graft Or Rhbmp2 (477) and Verte-Stack Spinal System (5). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.